Literature DB >> 32000788

Application of antigen presenting cell-targeted nanovaccine delivery system in rhabdovirus disease prophylactics using fish as a model organism.

Chen Zhang1, Gao-Xue Wang1, Bin Zhu2,3.   

Abstract

BACKGROUND: Targeted delivery of virus-associated antigens to professional antigen-presenting cells (APCs) is considered as an efficient strategy to enhance the pyrophytic effect of vaccines against rhabdovirus disease.
MATERIALS AND METHODS: In this study, we constructed a targeted carbon nanotubes-based vaccine deliver system (SWCNTs-MG) which can recognize the signature receptor (mannose) of APCs. An environmentally and economically important disease called spring viremia of carp (SVC) was studied as a model to evaluate the feasibility of single-walled carbon nanotubes (SWCNTs) conjugated with mannosylated antigen for rhabdovirus prevention.
RESULTS: Results showed that SWCNTs-MG could cross into fish body and present to internal immune-related tissues through gill, muscle and intestine within 6 h immersed vaccination. With further modification of mannose moiety, the obtained nanovaccine showed enhanced uptake by carp macrophages and immune-related tissues, which would then trigger strong immune responses against spring viremia of carp virus (SVCV) infection. Moreover, the survival rate of fish vaccinated with SWCNTs-MG (30 mg/L) was 63.5% after SVCV infection, whereas it was 0% for the control group.
CONCLUSION: This study not only provide a theoretical basis and research template for the application of targeted nanovaccine system in aquatic animals, but also play an important role in supporting development of healthy aquaculture and ensuring the safety of aquatic products and ecology.

Entities:  

Keywords:  Carbon nanotubes; Immune response; Mannose; Rhabdovirus; Targeted nanovaccine

Year:  2020        PMID: 32000788     DOI: 10.1186/s12951-020-0584-x

Source DB:  PubMed          Journal:  J Nanobiotechnology        ISSN: 1477-3155            Impact factor:   10.435


  4 in total

Review 1.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

2.  A Nanobody-Mediated Virus-Targeting Drug Delivery Platform for the Central Nervous System Viral Disease Therapy.

Authors:  Song Zhu; Fei Luo; Bin Zhu; Fei Ling; Er-Long Wang; Tian-Qiang Liu; Gao-Xue Wang
Journal:  Microbiol Spectr       Date:  2021-11-24

3.  Bioinformatic Design of Dendritic Cell-Specific Synthetic Promoters.

Authors:  Abayomi O Johnson; Susan B Fowler; Carl I Webster; Adam J Brown; David C James
Journal:  ACS Synth Biol       Date:  2022-04-07       Impact factor: 5.249

4.  Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.

Authors:  Michael D Lucroy; Ryan M Clauson; Mark A Suckow; Ferris El-Tayyeb; Ashley Kalinauskas
Journal:  BMC Vet Res       Date:  2020-11-18       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.